Viewing Study NCT03699956


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-29 @ 3:11 PM
Study NCT ID: NCT03699956
Status: TERMINATED
Last Update Posted: 2024-03-26
First Post: 2018-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer
Sponsor: EpicentRx, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module